Blue Cross and Blue Shield of Texas policy
Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia is a public Blue Cross and Blue Shield of Texas policy (policy SUR703.027). It lists 7 CPT or HCPCS codes. Not a coverage decision; the payer's own document governs.
View the original policy (PDF) ↗
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- SUR703.027
- Line of business
- Commercial, Medicaid
- Source
- medicalpolicy.hcsc.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Open official prior authorization lists to check the member’s product.
| Code | Other Blue Cross and Blue Shield of Texas policies |
|---|---|
| 38205 | Policies naming 38205 |
| 38206 | Policies naming 38206 |
| 38230 | Policies naming 38230 |
| 38232 | Policies naming 38232 |
| 38240 | Policies naming 38240 |
| 38241 | Policies naming 38241 |
| C9782 | Policies naming C9782 |
All Blue Cross and Blue Shield of Texas policies · Blue Cross and Blue Shield of Texas prior authorization CPT list